|
PPAT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.238100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.302500E-03 |
| Normal-vs-Stage2 |
6.094200E-02 |
| Normal-vs-Stage3 |
7.386800E-04 |
| Normal-vs-Stage4 |
5.223400E-04 |
| Stage1-vs-Stage2 |
5.105200E-01 |
| Stage1-vs-Stage3 |
5.670200E-01 |
| Stage1-vs-Stage4 |
4.416800E-01 |
| Stage2-vs-Stage3 |
3.369200E-01 |
| Stage2-vs-Stage4 |
2.652400E-01 |
| Stage3-vs-Stage4 |
7.599800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.995000E-04 |
| Normal-vs-AfricanAmerican |
3.087500E-02 |
| Normal-vs-Asian |
6.26759999999837E-05 |
| Caucasian-vs-AfricanAmerican |
9.170200E-01 |
| Caucasian-vs-Asian |
1.517620E-01 |
| AfricanAmerican-vs-Asian |
3.303200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.209250E-04 |
| Normal-vs-Female |
2.115200E-03 |
| Male-vs-Female |
2.046800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.624800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.2808999999957E-05 |
| Normal-vs-Age(61-80Yrs) |
2.090300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.343200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.066810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.213600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.390600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.578200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.344600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.834000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.944600E-01 |
| Classical-VS-Follicular |
9.805600E-01 |
| Classical-VS-Other |
1.854230E-01 |
| Classical-VS-Normal |
1.297580E-03 |
| Tall-VS-Follicular |
6.855800E-01 |
| Tall-VS-Other |
1.555560E-01 |
| Tall-VS-Normal |
8.203700E-02 |
| Follicular-VS-Other |
2.689000E-01 |
| Follicular-VS-Normal |
8.198300E-03 |
| Other-VS-Normal |
7.040800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.723080E-03 |
| Normal-vs-N1 |
2.007200E-04 |
| N0-vs-N1 |
2.632400E-01 |
|
|
